HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Hair Supplement Linked To Cases Of Severe Hepatitis In France

Executive Summary

France's ANSES warns women using oral contraceptives not to use a supplement marketed by UK firm Hairburst after linking the product's consumption to two cases of severe acute hepatitis.

You may also be interested in...



France Warns Supplements Can Interfere With Immune Response To COVID-19

Dietary supplements containing certain plants can inhibit the immune response to COVID-19 and should not be taken by those showing symptoms of the virus, according to French regulator ANSES.

ASA Takes Shears To Hairburst Ad Claims; Volume & Growth Elixir Will Need Name Change

Hairburst’s hair-growth and hair-loss prevention claims on cosmetic products are inadequately substantiated, and many of the health claims it uses to promote food supplements are unauthorized, the Advertising Standards Authority says in a 14 Aug. decision.

Marinomed Takes Virus-Blocking Device Into Allergy And Dry Eye Categories

Virus-blocking compound Carragelose, out-licensed to major consumer health players such as Perrigo and Reckitt for use in OTC respiratory nasal sprays, is being adapted for use in the dry eye and allergy categories.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

RS150747

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel